Search Within

Hong Zhang

Formats
  1. Meeting Abstract (28)
  2. Journal Article (24)
  3. Miscellaneous (1)
  4. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Sloan Kettering Institute Postdocs (30)
  3. GSK Faculty (29)
  4. GDMT, Pathology and Laboratory Medicine (26)
  5. Gynecology Disease Management Team (26)
  6. Breast Medicine Service (18)

More Groups

People
  1. Edi Brogi (29)
  2. Hannah Wen (29)
  3. Fresia Pareja Zea (27)
  4. Jorge Reis-Filho (27)
  5. Britta Weigelt (26)
  6. Edaise Da Silva (21)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (13)
  5. 2021 (8)
  6. 2020 (11)

More Years

Publications
  1. Laboratory Investigation (15)
  2. Cancer Research (6)
  3. npj Breast Cancer (5)
  4. Annals of Oncology (4)
  5. Modern Pathology (4)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. Nature Publishing Group (20)
  2. American Association for Cancer Research (7)
  3. Nature Research (4)
  4. Oxford University Press (4)
  5. BMJ Publishing Group Ltd. (2)
  6. College of American Pathologists (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin-induced apoptosis
    Journal Article

    Wang, M.; Liang, L.; Lu, J.; Yu, Y.; Zhao, Y.; Shi, Z.; Li, H.; Xu, X.; Yan, Y.; Niu, Y.; more...
    Thoracic Cancer (2019)

    Fulltext@MSK | Save
  • Molecular determinants of post-mastectomy breast cancer recurrence
    Journal Article

    Keene, K. S.; King, T.; Hwang, E. S.; Peng, B.; McGuire, K. P.; Tapia, C.; Zhang, H.; Bae, S.; Nakhlis, F.; Klauber-Demore, N.; more...
    npj Breast Cancer (2018)

    Fulltext@MSK | Save
  • Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers
    Journal Article

    Wang, M.; Liang, L.; Lei, X.; Multani, A.; Meric-Bernstam, F.; Tripathy, D.; Wu, Y.; Chen, H.; Zhang, H.
    Annals of Diagnostic Pathology (2018)

    Fulltext@MSK | Save
  • Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway
    Journal Article

    Guo, K. Y.; Han, L.; Li, X.; Yang, A. V.; Lu, J.; Guan, S.; Li, H.; Yu, Y.; Zhao, Y.; Yang, J.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save